135 related articles for article (PubMed ID: 8546997)
1. A comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis.
Buckley DA; Healy E; Rogers S
Br J Dermatol; 1995 Sep; 133(3):417-22. PubMed ID: 8546997
[TBL] [Abstract][Full Text] [Related]
2. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
Kirby B; Buckley DA; Rogers S
Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
[TBL] [Abstract][Full Text] [Related]
3. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
4. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
[TBL] [Abstract][Full Text] [Related]
5. Twice- vs. thrice-weekly MPD PUVA in psoriasis: a randomized-controlled efficacy study.
Valbuena MC; Hernández O; Rey M; Sánchez G; de Quintana LP
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):126-9. PubMed ID: 17598865
[TBL] [Abstract][Full Text] [Related]
6. Comparison of minimal phototoxic dose and skin type for determining initial UVA dose in oral liquid methoxsalen photochemotherapy for the treatment of psoriasis.
Rafal ES; Hamilton TA; Gonzalez E
J Invest Dermatol; 1991 Dec; 97(6):1048-52. PubMed ID: 1748814
[TBL] [Abstract][Full Text] [Related]
7. Response of psoriasis to twice weekly PUVA.
Sakuntabhai A; Sharpe GR; Farr PM
Br J Dermatol; 1993 Feb; 128(2):166-71. PubMed ID: 8457450
[TBL] [Abstract][Full Text] [Related]
8. A modified dosage schedule for increased efficiency in PUVA treatment of psoriasis.
Carabott FM; Hawk JL
Clin Exp Dermatol; 1989 Sep; 14(5):337-40. PubMed ID: 2612036
[TBL] [Abstract][Full Text] [Related]
9. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
Speight EL; Farr PM
Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
[TBL] [Abstract][Full Text] [Related]
10. Minimal phototoxic dose (MPD) measurements for topical photochemotherapy using a semiautomated MPD tester.
Al-Ismail D; Edwards C; Al-Ofi O; Anstey AV
Br J Dermatol; 2013 Sep; 169(3):687-9. PubMed ID: 23607709
[TBL] [Abstract][Full Text] [Related]
11. Cumulative UV radiation dose and outcome in clinical practice: effectiveness of trioxsalen bath PUVA with minimal UVA exposure.
Snellman E; Rantanen T; Sundell J
Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):207-10. PubMed ID: 11068859
[TBL] [Abstract][Full Text] [Related]
12. Comparison of turbo-PUVA and conventional American-style PUVA in the treatment of psoriatic patients.
Moneib HA; Salem SA; Younis RM
Photodermatol Photoimmunol Photomed; 2010 Aug; 26(4):205-10. PubMed ID: 20626823
[TBL] [Abstract][Full Text] [Related]
13. Shower PUVA: a novel variant of photochemotherapy. Distribution of photosensitivity and accumulation of trioxsalen in the skin.
Sánchez Ruderisch H; Aryee-Boi J; Schwarz C; Radenhausen M; Tebbe B
Skin Pharmacol Physiol; 2004; 17(3):129-32. PubMed ID: 15087592
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis.
Calzavara-Pinton PG; Ortel B; Hönigsmann H; Zane C; De Panfilis G
Dermatology; 1994; 189(3):256-9. PubMed ID: 7949478
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis.
Shehzad T; Dar NR; Zakria M
J Pak Med Assoc; 2004 Sep; 54(9):453-5. PubMed ID: 15518366
[TBL] [Abstract][Full Text] [Related]
16. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
17. PUVA treatment of psoriasis in the United Kingdom.
Farr PM; Diffey BL
Br J Dermatol; 1991 Apr; 124(4):365-7. PubMed ID: 2025557
[TBL] [Abstract][Full Text] [Related]
18. Half-side comparison of erythemogenic versus suberythemogenic UVA doses in oral photochemotherapy of psoriasis.
Tanew A; Ortel B; Hönigsmann H
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):408-13. PubMed ID: 10459114
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
